Areta Kupchyk - Jun 13, 2024 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ Areta Kupchyk
Stock symbol
ANEB
Transactions as of
Jun 13, 2024
Transactions value $
$0
Form type
4
Date filed
6/17/2024, 04:23 PM
Previous filing
Oct 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +41.7K $0.00 41.7K Jun 13, 2024 Common Stock 41.7K $2.10 Direct F1
transaction ANEB Stock Option (right to buy) Award $0 +1.32K $0.00 1.32K Jun 13, 2024 Common Stock 1.32K $2.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest 50% on the date of the 2024 annual meeting of shareholders and 50% on the one year anniversary of the date of grant
F2 These stock options vest on the earlier of November 30,2024 or the date of the 2024 annual meeting of shareholders

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney (Areta Kupchyk)